NCT03629873 2022-01-03
Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
The First Affiliated Hospital with Nanjing Medical University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Heidelberg University